← Today’s ReceiptsOfficial public filing linked
Public-record receiptR-TXOfficial filing linked
Michael McCaul disclosed BUY $MRK
Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.
Trade range
$100K – $250K
Filed
2025-05-12
Trade date
2025-04-02
Disclosure lag
40 days after trade
Why this receipt matters
A quick read before you share it.
These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.
1The receipt links to an official public filing, so readers can verify the underlying disclosure before sharing.
2The filing appeared 40 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $100K – $250K, which is the public reporting band rather than an exact profit or loss figure.
411 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Michael McCaul, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 28 lobbying filings.
Source
Official filing ↗
Source: official House/Senate financial disclosure record · filing ID 8220904 · filed 2025-05-12 · disclosed 40d after transaction
Market context
Merck & Co. Inc.
Sector: Healthcare
Vs SPY: 4.3%
Factual flags
- 28 lobbying filings linked to this ticker.
- 11 nearby same-ticker disclosures in the surrounding 30-day window.
- Traded MRK 19d before lobbying filing by MERCK & CO INC ($2,600,000)
- 53 trades filed on 2025-05-12 (batch dump)
- 3 members traded MRK within 7 days (starting 2025-03-31)
- Trade upper bound: $250,000
Member trail
Michael McCaul
U.S. House · TX-10
House Committee on Homeland SecurityHouse Committee on Foreign Affairs
Ticker trail
$MRK
Merck & Co. Inc.
Follow this tickerAlert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.